Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma

Published:2018-03-10 Issue:5 Volume:39 Page:689-699
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Zhang Xuyao¹,Chen Wei¹,Fan Jiajun¹,Wang Shaofei¹²,Xian Zongshu¹,Luan Jingyun¹,Li Yubin¹²,Wang Yichen¹,Nan Yanyang¹,Luo Man¹,Li Song³,Tian Wenzhi³,Ju Dianwen¹

Affiliation:

1. Department of Microbiological and Biochemical Pharmacy, The Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China

2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

3. ImmuneOnco Biopharma (Shanghai) Co., Ltd., Shanghai, China

Funder

National Key Basic Research Program of China

National Natural Science Foundation of China

Shanghai Science and Technology Funds

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/39/5/689/24774171/bgy041.pdf

Reference50 articles.

1. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway;Sareddy;Oncogene,2017

2. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance;Kim;Nature,2015

3. Short-course radiation plus temozolomide in elderly patients with glioblastoma;Perry;N. Engl. J. Med,2017

4. Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors;Danilova;Proc. Natl. Acad. Sci. U.S.A,2016

5. Unravelling the biology of SCLC: implications for therapy;Sabari;Nat. Rev. Clin. Oncol,2017

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer;Cell Death Discovery;2024-09-03

2. Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond;Current Issues in Molecular Biology;2024-07-23

3. Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution;Cell Communication and Signaling;2024-06-18

4. Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy;Discover Oncology;2024-05-25

5. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review);International Journal of Oncology;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3